Page last updated: 2024-10-24

carvedilol and Chronic Liver Failure

carvedilol has been researched along with Chronic Liver Failure in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Propranolol has been used as prophylaxis for variceal bleeding in patients with cirrhosis."6.82A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis. ( Baik, SK; Jang, JY; Jeong, SW; Kim, DJ; Kim, MY; Kim, SG; Kim, TY; Kim, YS; Lee, B; Seo, YS; Sohn, JH; Suk, KT; Um, SH, 2016)
"Ivabradine combined with carvedilol improves LVDD, achieves THR more often and reduces risk of encephalopathy, acute kidney injury with improved survival in patients with cirrhosis."2.94Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis. ( Goyal, R; Khumuckham, JS; Kumar, G; Premkumar, M; Rangegowda, D; Sarin, SK; Shasthry, SM; Thomas, SS; Vyas, T, 2020)
"Propranolol has been used as prophylaxis for variceal bleeding in patients with cirrhosis."2.82A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis. ( Baik, SK; Jang, JY; Jeong, SW; Kim, DJ; Kim, MY; Kim, SG; Kim, TY; Kim, YS; Lee, B; Seo, YS; Sohn, JH; Suk, KT; Um, SH, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Premkumar, M1
Rangegowda, D1
Vyas, T1
Khumuckham, JS1
Shasthry, SM1
Thomas, SS1
Goyal, R1
Kumar, G1
Sarin, SK1
Kim, SG1
Kim, TY1
Sohn, JH1
Um, SH1
Seo, YS1
Baik, SK1
Kim, MY1
Jang, JY1
Jeong, SW1
Lee, B1
Kim, YS1
Suk, KT1
Kim, DJ1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy of Carvedilol + Ivabradine vs Carvedilol Alone for Left Ventricular Diastolic Dysfunction in Chronic Liver Disease Patients and Its' Impact on Morbidity and Mortality; a Prospective Randomized Controlled Trial.[NCT04111133]130 participants (Anticipated)Interventional2020-01-01Recruiting
Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its' Impact on Morbidity and Mortality[NCT02294292]189 participants (Actual)Interventional2014-07-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for carvedilol and Chronic Liver Failure

ArticleYear
Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis.
    Journal of clinical gastroenterology, 2020, Volume: 54, Issue:6

    Topics: Carvedilol; End Stage Liver Disease; Humans; Ivabradine; Liver Cirrhosis; Severity of Illness Index

2020
Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis.
    Journal of clinical gastroenterology, 2020, Volume: 54, Issue:6

    Topics: Carvedilol; End Stage Liver Disease; Humans; Ivabradine; Liver Cirrhosis; Severity of Illness Index

2020
Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis.
    Journal of clinical gastroenterology, 2020, Volume: 54, Issue:6

    Topics: Carvedilol; End Stage Liver Disease; Humans; Ivabradine; Liver Cirrhosis; Severity of Illness Index

2020
Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis.
    Journal of clinical gastroenterology, 2020, Volume: 54, Issue:6

    Topics: Carvedilol; End Stage Liver Disease; Humans; Ivabradine; Liver Cirrhosis; Severity of Illness Index

2020
A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:11

    Topics: Adult; Antihypertensive Agents; Ascites; Carbazoles; Carvedilol; End Stage Liver Disease; Esophageal

2016